Ngā hua rapu - Pronk, L C
- E whakaatu ana i te 1 - 4 hua o te 4
-
1
-
2
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours mā Pronk, L C, Vasey, P, Sparreboom, A, Reigner, B, Planting, A S Th, Gordon, R J, Osterwalder, B, Verweij, J, Twelves, C
I whakaputaina 2000Text -
3
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. mā Pronk, L. C., Schrijvers, D., Schellens, J. H., de Bruijn, E. A., Planting, A. S., Locci-Tonelli, D., Groult, V., Verweij, J., van Oosterom, A. T.
I whakaputaina 1998Text -
4
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours mā Attard, G, Kitzen, J, Blagden, S P, Fong, P C, Pronk, L C, Zhi, J, Zugmaier, G, Verweij, J, de Bono, J S, de Jonge, M
I whakaputaina 2007Text